LeadIQ logo
Learn more at LeadIQ.com

Insights

Acquisition Strategy Stallergenes Greer has engaged in multiple acquisitions such as acquiring Palforzia and HAL Allergy Group. This signals a proactive growth strategy, presenting opportunities for cross-selling products and services to new customer bases.

Partnership Development The partnership with Nestlé for the peanut allergy treatment Palforzia showcases Stallergenes Greer's collaborative approach. Leveraging existing partnerships can yield new business opportunities through joint marketing efforts and expanded market reach.

Technology Integration Stallergenes Greer's development of a connected device and mobile app for patients receiving AIT treatments demonstrates a focus on enhancing patient experience. Leveraging innovative technology can attract tech-savvy customers and differentiate the company's offerings in the market.

Financial Stability With revenues ranging between $100 million to $1 billion and funding of $53 million, Stallergenes Greer demonstrates financial strength. This stability can be leveraged to offer competitive pricing, invest in R&D, and attract potential investors or partners.

Competitive Differentiation In a competitive landscape with companies like DBV Technologies and Allergy Therapeutics, Stallergenes Greer stands out with its diverse product portfolio and global presence. Highlighting these strengths can position the company as a preferred partner for healthcare professionals seeking comprehensive allergy solutions.

Similar companies to Stallergenes Greer

Stallergenes Greer Tech Stack

Stallergenes Greer uses 8 technology products and services including Corel, CoinHive, Veeva Systems CRM, and more. Explore Stallergenes Greer's tech stack below.

  • Corel
    Communication And Collaboration
  • CoinHive
    Cryptominers
  • Veeva Systems CRM
    Customer Relationship Management
  • UKG
    Human Resource Management System
  • OWL Carousel
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • Adobe Creative Suite
    Visualisation Software
  • Facebook
    Widgets

Media & News

Stallergenes Greer's Email Address Formats

Stallergenes Greer uses at least 1 format(s):
Stallergenes Greer Email FormatsExamplePercentage
First.Last@stallergenesgreer.comJohn.Doe@stallergenesgreer.com
70%
FLast@stallergenesgreer.comJDoe@stallergenesgreer.com
25%
Last.First@stallergenesgreer.comDoe.John@stallergenesgreer.com
3%
FirLast@stallergenesgreer.comJohDoe@stallergenesgreer.com
2%

Frequently Asked Questions

Where is Stallergenes Greer's headquarters located?

Minus sign iconPlus sign icon
Stallergenes Greer's main headquarters is located at Zugerstrasse 76b Baar, Switzerland 6340 CH. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Stallergenes Greer's phone number?

Minus sign iconPlus sign icon
You can contact Stallergenes Greer's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Stallergenes Greer's official website and social media links?

Minus sign iconPlus sign icon
Stallergenes Greer's official website is stallergenesgreer.com and has social profiles on LinkedIn.

How much revenue does Stallergenes Greer generate?

Minus sign iconPlus sign icon
As of September 2024, Stallergenes Greer's annual revenue reached $750M.

What is Stallergenes Greer's SIC code NAICS code?

Minus sign iconPlus sign icon
Stallergenes Greer's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 325414 - Biological Product (except Diagnostic) Manufacturing.

How many employees does Stallergenes Greer have currently?

Minus sign iconPlus sign icon
As of September 2024, Stallergenes Greer has approximately 1.1K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: R. R.Chief Commercial Officer: P. T.Vice President Commercial Operations D-A-Ch Region/ Geschäftsführer D-A-Ch Region: A. M.. Explore Stallergenes Greer's employee directory with LeadIQ.

What industry does Stallergenes Greer belong to?

Minus sign iconPlus sign icon
Stallergenes Greer operates in the Pharmaceutical Manufacturing industry.

What technology does Stallergenes Greer use?

Minus sign iconPlus sign icon
Stallergenes Greer's tech stack includes CorelCoinHiveVeeva Systems CRMUKGOWL CarouselBootstrapAdobe Creative SuiteFacebook.

What is Stallergenes Greer's email format?

Minus sign iconPlus sign icon
Stallergenes Greer's email format typically follows the pattern of . Find more Stallergenes Greer email formats with LeadIQ.

How much funding has Stallergenes Greer raised to date?

Minus sign iconPlus sign icon
As of September 2024, Stallergenes Greer has raised $53M in funding. The last funding round occurred on Dec 01, 2016 for $53M.

When was Stallergenes Greer founded?

Minus sign iconPlus sign icon
Stallergenes Greer was founded in 2015.
Stallergenes Greer

Stallergenes Greer

Pharmaceutical ManufacturingSwitzerland, Switzerland1001-5000 Employees

Stallergenes Greer is a global biopharmaceutical company specialising in the diagnosis and treatment of respiratory, food allergies and venoms through the research, development and commercialisation of allergen immunotherapy products and services. 

Our purpose is to enable precision medicine to improve life for people with allergies. 
With nearly 1,100 employees worldwide, a presence in 44 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer International AG is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France). 

With complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy.

Link to our privacy policy: https://www.stallergenesgreer.com/personal-data-protection-policy

Section iconCompany Overview

Headquarters
Zugerstrasse 76b Baar, Switzerland 6340 CH
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
325414 - Biological Product (except Diagnostic) Manufacturing
Founded
2015
Employees
1001-5000

Section iconFunding & Financials

  • $53M

    Stallergenes Greer has raised a total of $53M of funding over 1 rounds. Their latest funding round was raised on Dec 01, 2016 in the amount of $53M.

  • $100M$1B

    Stallergenes Greer's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $53M

    Stallergenes Greer has raised a total of $53M of funding over 1 rounds. Their latest funding round was raised on Dec 01, 2016 in the amount of $53M.

  • $100M$1B

    Stallergenes Greer's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.